respiratori
viru
infect
repres
major
public
health
problem
worldwid
occurr
eas
spread
commun
consider
morbid
mortal
mortal
respiratori
viru
infect
healthi
individu
develop
countri
rare
howev
less
develop
countri
childhood
mortal
quit
high
estim
million
children
global
year
die
annual
respiratori
viru
infect
worldwid
occurr
result
peopl
age
suscept
respiratori
viru
infect
howev
averag
children
infect
two
three
time
frequent
adult
acut
respiratori
viru
infect
common
infect
experienc
healthi
children
often
result
loss
school
time
signific
socioeconom
cost
medic
visit
medic
parent
loss
work
time
virus
transmit
direct
contact
droplet
although
transmit
aerosol
virus
primarili
infect
respiratori
tract
includ
influenza
adenovirus
parainfluenza
virus
respiratori
syncyti
viru
rsv
coronavirus
human
metapneumoviru
rhinovirus
enterovirus
recent
new
viru
bocaviru
identifi
influenza
parainfluenza
human
metapneumoviru
hmpv
rsv
occur
epidem
adenoviru
coronaviru
rhinovirus
occur
endem
virus
caus
respiratori
diseas
commonli
immunosuppress
peopl
includ
measl
varicella
zoster
viru
vzv
herp
simplex
viru
hsv
cytomegaloviru
cmv
aetiolog
diagnosi
viral
respiratori
tract
ill
requir
laboratori
confirm
symptom
sign
clinic
ill
lack
specif
permit
aetiolog
recognit
clinic
ground
alon
develop
safe
chemotherapeut
agent
highli
immunogenet
protect
vaccin
individu
respiratori
virus
continu
prioriti
except
influenza
viru
goal
remain
elus
respiratori
viru
infect
often
season
distribut
especi
temper
climat
peak
incid
vari
year
year
often
predomin
season
occurr
rsv
influenza
peak
incid
winter
peak
usual
coincid
overlap
parainfluenza
viru
piv
usual
peak
winter
piv
piv
peak
autumn
earli
winter
picornavirida
caus
infect
year
round
enterovirus
common
summer
autumn
rhinovirus
common
winter
spring
adenovirus
tend
caus
infect
year
round
herpesvirida
except
varicella
preval
late
winter
earli
spring
viral
cultur
origin
method
use
diagnos
respiratori
viru
infect
cultur
virus
use
primari
immort
cell
expand
wider
diagnost
use
main
advantag
tradit
cell
cultur
method
abil
isol
identifi
wide
rang
virus
enabl
identif
mani
virus
includ
commonli
caus
respiratori
infect
influenza
rsv
piv
adenovirus
measl
enterovirus
rhinovirus
vzv
cmv
hsv
recent
recogn
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
hmpv
also
grown
cell
cultur
viru
isol
success
care
attent
need
paid
number
issu
includ
select
appropri
patient
collect
adequ
specimen
transport
specimen
virolog
laboratori
optim
condit
process
method
clinic
sampl
respiratori
sampl
viru
isol
includ
nasopharyng
aspir
nasopharyng
andor
oropharyng
swab
nasopharyng
wash
bronchioalveolar
lavag
sputum
lung
biopsi
open
lung
biopsi
specimen
contamin
commens
respiratori
flora
dacron
polyest
swab
collect
respiratori
tract
place
viral
transport
medium
contain
antibiot
specimen
kept
cool
wet
ice
inocul
cell
cultur
maintain
viru
infect
especi
labil
virus
rsv
detect
virus
cell
cultur
requir
consider
expertis
perform
microscop
examin
look
degen
morpholog
chang
cell
monolay
call
cytopath
effect
cpe
virus
grow
cell
type
clinic
specimen
usual
inocul
sever
type
cell
provid
environ
isol
suitabl
rang
virus
use
broad
rang
cell
type
potenti
allow
isol
agent
expect
rather
limit
detect
viru
type
approach
also
allow
detect
one
viru
given
specimen
occur
immunocompet
individu
frequent
immunocompromis
patient
especi
virus
latenc
cmv
hsv
recent
commerci
produc
cocultiv
cryopreserv
cell
becom
avail
rapid
identif
virus
rmix
rapid
cell
cultur
diagnost
hybrid
patent
cell
monolay
contain
mixtur
mink
lung
cell
h
cultur
use
pool
singl
fluorescein
isothiocyan
fitc
label
monoclon
antibodi
direct
influenza
b
rsv
parainfluenza
adenovirus
rapid
identif
respiratori
viru
infect
establish
growth
viru
cell
cultur
indic
presenc
viabl
replic
compet
viru
find
determin
use
antigen
nucleic
acid
detect
addit
propag
isol
provid
viru
antivir
suscept
test
serotyp
epidemiolog
studi
recent
newer
viral
cultur
format
develop
allow
rapid
detect
virus
use
detect
virus
grow
slowli
convent
cell
cultur
decreas
time
cpe
detect
achiev
mani
virus
centrifug
cultur
sampl
ad
virus
unabl
centrifug
convent
centrifug
enhanc
detect
may
result
better
contact
cell
specimen
cell
cultur
thu
allow
earlier
extens
infect
cell
cultur
sheet
furthermor
detect
viral
protein
product
antigen
detect
evid
cpe
convent
cultur
also
decreas
time
identifi
viru
thu
enhanc
clinic
util
viral
cultur
test
detect
viral
protein
product
usual
perform
use
fluorescentlabel
eg
fitc
monoclon
antibodi
direct
viral
protein
process
read
cultur
labour
intens
howev
common
virus
detect
h
altern
enzymelink
immunosorb
assay
elisa
detect
viral
protein
cell
cultur
supernat
also
perform
activ
promot
technolog
exploit
allow
detect
use
babi
hampster
kidney
bhk
cell
line
stabli
transform
promot
hsv
link
escherichia
coli
lacz
gene
hsv
detect
within
h
infect
use
chromogen
substrat
turn
infect
cell
colourless
blue
hsv
infect
cell
easili
identifi
techniqu
could
expand
determin
viral
titr
specimen
requir
system
market
diagnost
hybrid
name
elvi
enzymelink
virusinduc
system
abil
detect
virus
significantli
enhanc
develop
monoclon
antibodi
mab
direct
specif
viral
protein
virus
vzv
cmv
influenza
influenza
b
parainfluenza
adenoviru
link
fluoresc
molecul
fitc
stain
procedur
rapid
sampl
batch
run
result
usual
avail
within
h
depend
number
specimen
test
rapid
immunofluoresc
stain
method
direct
detect
viral
antigen
respiratori
specimen
excel
specif
good
sensit
respiratori
virus
produc
cpe
convent
cell
cultur
often
slow
minim
extent
rapid
detect
respiratori
virus
influenza
influenza
b
parainfluenza
adenoviru
avail
mani
laboratori
extrem
use
detect
virus
especi
paediatr
patient
shed
rel
larg
amount
viru
longer
period
adult
perform
characterist
test
depend
type
specimen
age
patient
durat
ill
mab
reagent
level
expertis
laboratori
staff
gener
method
respiratori
virus
littl
less
sensit
cultur
except
rsv
howev
greater
sensit
rsv
compar
rsv
cultur
due
labil
rsv
rapidli
inactiv
sampl
kept
refriger
transport
laboratori
quickli
inocul
cell
cultur
within
short
period
collect
specimen
report
sensit
detect
respiratori
virus
vari
broadli
rsv
influenza
b
parainfluenza
adenovirus
mab
direct
hmpv
develop
current
investig
establish
clinic
util
membranebas
cassettebas
enzym
immunoassay
eia
optic
immunoassay
immunochromograph
lateralflow
system
introduc
less
technic
demand
detect
respiratori
virus
differenti
virus
eg
influenza
influenza
b
rsv
influenza
includ
posit
control
monitor
perform
assay
user
signific
aim
manufactur
test
allow
test
occur
consult
physician
offic
techniqu
advantag
decreas
turnaround
time
test
result
consider
simplifi
technic
compon
test
sensit
specif
viral
cultur
direct
dif
detect
respiratori
virus
posit
predict
valu
assay
usual
higher
greater
preval
diseas
respiratori
viru
season
viru
question
shown
circul
commun
viral
cultur
period
rel
high
preval
posit
result
usual
accept
correct
howev
neg
result
confirm
second
method
eg
dif
cultur
virus
detect
clinic
sampl
use
highli
specif
nucleic
acid
probe
complementari
sequenc
viral
rna
viral
dna
use
nucleic
acid
amplif
techniqu
polymeras
chain
reaction
pcr
branch
chain
dna
detect
bdna
nucleic
acid
sequenc
base
amplif
nasba
techniqu
becom
increasingli
avail
diagnost
laboratori
test
multipl
virus
use
molecular
method
consider
expens
convent
techniqu
methodolog
need
develop
hous
evid
would
suggest
test
use
molecular
method
littl
sensit
convent
approach
inform
avail
date
variabl
influenza
viru
isol
influenza
b
influenza
c
viru
influenza
b
virus
belong
famili
orthomyxovirida
genu
influenzaviru
influenza
c
viru
belong
separ
genu
influenza
virion
envelop
particl
ie
surround
lipid
bilay
membran
cellular
origin
contain
singlestrand
negativesens
segment
rna
genom
surround
helic
capsid
influenza
b
contain
eight
segment
rna
influenza
c
contain
seven
segment
influenza
b
clinic
import
influenza
c
infect
occur
uncommonli
usual
associ
mild
upper
respiratori
tract
ill
rare
caus
bronchiti
pneumonia
envelop
virion
peplom
spike
consist
two
glycoprotein
haemagglutinin
h
involv
attach
viru
cell
initi
infect
neuraminidas
n
facilit
releas
newli
form
virion
cell
two
glycoprotein
h
n
exhibit
substanti
antigen
variat
among
influenza
virus
h
subtyp
n
subtyp
recogn
influenza
b
one
type
h
n
glycoprotein
occurr
annual
influenza
epidem
throughout
world
due
high
rate
antigen
variat
stepwis
mutat
h
n
gene
reflect
variat
antigen
characterist
protein
thu
escap
immun
memori
h
n
glycoprotein
influenza
b
virus
stepwis
mutat
h
n
result
antigen
drift
recurr
annual
influenza
epidem
seen
winter
viru
infect
produc
diseas
among
popul
would
otherwis
possess
immun
previou
infect
antibodi
fail
recogn
new
antigen
variat
reason
necess
annual
influenza
vaccin
differ
serotyp
influenza
b
virus
addit
segment
natur
influenza
genom
allow
antigen
shift
reassort
genom
segment
two
differ
influenza
virus
major
chang
h
n
protein
major
variat
genet
makeup
give
influenza
viru
potenti
develop
global
pandem
past
year
new
influenza
virus
isol
hong
kong
appear
spread
poultri
small
number
person
shown
high
mortal
rate
caus
high
degre
global
concern
spread
avian
influenza
strain
human
usual
uncommon
sever
hundr
human
case
infect
identifi
countri
across
world
major
limit
viru
caus
pandem
huge
impact
health
economi
failur
influenza
establish
sustain
humantohuman
transmiss
occur
pandem
would
inevit
commonli
avail
routin
diagnost
test
laboratori
differenti
influenza
influenza
b
howev
unabl
identifi
subtyp
identif
strain
influenza
perform
varieti
method
refer
laboratori
requir
laboratori
diagnosi
influenza
viru
infect
isol
viru
cell
cultur
gold
standard
techniqu
techniqu
howev
slow
allow
diagnosi
within
time
frame
specif
treatment
howev
viru
isol
remain
critic
import
epidemiolog
studi
recognit
specif
type
influenza
circul
commun
identif
new
type
thu
pandem
inform
influenza
type
use
design
vaccin
upcom
influenza
season
influenza
cultur
perform
nasopharyng
aspir
nasopharyng
swab
throat
swab
sputum
lung
biopsi
tissu
bronchoalveolar
lavag
specimen
kept
process
recent
rapid
cultur
involv
growth
influenza
day
label
cell
antibodi
direct
influenza
use
immunoperoxidas
fluoresc
techniqu
develop
techniqu
rapid
rel
inexpens
requir
high
degre
technic
compet
accur
differenti
influenza
b
virus
suitabl
identifi
h
type
influenza
thu
test
would
diagnost
earli
stage
pandem
new
h
type
influenza
would
cocircul
old
h
type
direct
detect
viral
antigen
respiratori
specimen
also
perform
techniqu
choic
rapid
sensit
assay
revers
transcriptionpolymeras
chain
reaction
rtpcr
avail
mani
laboratori
differenti
influenza
b
virus
also
use
identifi
differ
h
n
type
influenza
detect
immunolog
respons
fourfold
greater
rise
serum
antibodi
titr
use
haemagglutin
inhibit
complement
fixat
techniqu
acut
convalesc
sampl
compar
also
provid
evid
acut
infect
influenza
b
viru
serolog
test
rare
diagnost
individu
case
within
timefram
allow
judici
use
antiinfluenza
drug
use
track
epidem
commun
elisa
test
igm
singl
sampl
also
avail
igm
iga
specif
antibodi
influenza
peak
day
infect
igg
specif
antibodi
peak
week
serolog
diagnosi
type
influenza
viru
complic
fact
anamnest
respons
infect
highest
strain
caus
primari
infect
even
subsequ
infect
strain
term
doctrin
origin
antigen
sin
lead
lack
strain
specif
serolog
test
parainfluenza
viru
type
occur
worldwid
among
person
age
group
parainfluenza
virus
much
less
frequent
parainfluenza
occur
epidem
usual
autumn
altern
year
parainfluenza
occur
sporad
parainfluenza
tend
caus
annual
winter
epidem
temper
climat
parainfluenza
main
caus
croup
infant
young
children
year
age
parainfluenza
also
caus
viral
pneumonia
bronchiol
infant
small
children
parainfluenza
occur
infrequ
usual
associ
mild
symptom
upper
respiratori
tract
ill
rhinorrhea
pharyng
cough
primari
infect
parainfluenza
provid
measur
immun
immun
complet
long
last
reinfect
occur
commonli
rare
sever
ill
seen
primari
infect
laboratori
diagnosi
parainfluenza
infect
base
viral
isol
tissu
cultur
remain
gold
standard
respiratori
secret
specimen
must
kept
process
parainfluenza
grow
rel
slowli
take
day
virus
caus
direct
cpe
detect
use
haemadsorpt
adsorpt
guinea
pig
red
blood
cell
infect
cell
rapid
diagnost
test
detect
viral
antigen
respiratori
specimen
use
dif
specif
parainfluenza
viru
type
show
high
sensit
specif
rtpcr
procedur
either
detect
singl
virus
parainfluenza
group
high
sensit
specif
serolog
respons
detect
fourfold
greater
rise
serum
antibodi
level
acut
convalesc
sampl
collect
week
onset
acut
ill
may
also
provid
evid
infect
antibodi
measur
use
complement
fixat
haemagglutin
inhibit
neutral
interpret
serolog
test
rel
parainfluenza
type
produc
infect
may
complic
heterotop
antibodi
respons
seen
infect
individu
rsv
first
isol
laboratori
chimpanze
ill
resembl
common
cold
shortli
demonstr
human
pathogen
epidemiolog
studi
shown
rsv
repres
singl
import
caus
seriou
lower
respiratori
tract
diseas
especi
bronchiol
pneumonia
infant
children
rsv
caus
sever
pneumonia
death
person
underli
immun
defici
rsv
belong
famili
paramyxovirida
genu
pneumoviru
envelop
viru
singlestrand
negativesens
nonseg
rna
genom
least
viral
protein
antigen
analysi
rsv
identifi
two
subgroup
b
base
reactiv
panel
monoclon
antibodi
b
strain
differenti
two
variant
annual
epidem
rsv
occur
winter
temper
climat
two
subgroup
usual
cocircul
geograph
area
often
predomin
subgroup
diagnosi
rsv
commonli
made
direct
examin
respiratori
secret
use
eia
techniqu
number
commerci
rapid
pointofcar
diagnost
eia
kit
identifi
rsv
antigen
respiratori
secret
avail
kit
provid
high
degre
sensit
specif
although
sensit
dif
rsv
also
grown
cell
cultur
viru
extrem
labil
great
care
must
taken
transport
ensur
remain
rsv
also
diagnos
serolog
use
complement
fixat
detect
fourfold
rise
antibodi
titr
howev
like
respiratori
viru
serolog
test
clinic
use
delay
diagnosi
furthermor
infant
may
possess
matern
antibodi
thu
complic
interpret
serolog
data
adenovirus
isol
primari
cell
cultur
adenoid
children
earli
adenovirus
nonenvelop
particl
contain
linear
doublestrand
dna
surround
icosahedr
capsid
fibrelik
project
extend
capsid
vertic
adenoviru
infect
occur
worldwid
transmiss
vari
sporad
epidem
sinc
adenovirus
stabl
easili
transmit
environ
fomit
adenovirus
import
caus
upper
lower
respiratori
tract
diseas
type
account
infect
rare
adenovirus
isol
lung
liver
kidney
brain
patient
fatal
infect
adenovirus
isol
cell
cultur
presumpt
recogn
characterist
cytopath
effect
current
human
adenoviru
serotyp
identifi
group
six
subgenera
design
f
base
differ
classif
scheme
concern
guanin
g
cytosin
c
content
dna
determin
use
dna
restrict
analysi
procedur
pcr
individu
isol
serotyp
use
haemagglutin
inhibit
neutral
howev
time
consum
routin
avail
adenovirus
detect
directli
respiratori
secret
use
pcr
elisa
immunochromatographi
adenoviru
infect
diagnos
serolog
use
complement
fixat
detect
fourfold
greater
rise
antibodi
titr
convalesc
typespecif
antibodi
respons
assay
haemagglutin
inhibit
elisa
neutral
assay
howev
except
epidemiolog
investig
antibodi
determin
much
less
effici
mean
determin
infect
use
direct
method
pcr
antigen
detect
rhinovirus
group
serotyp
caus
common
cold
minor
upper
respiratori
tract
ill
viru
infect
respiratori
tract
account
one
half
common
cold
occur
children
consequ
caus
substanti
absente
school
person
underli
lung
diseas
immun
disord
rhinovirus
caus
pneumonia
rhinovirus
belong
famili
picornavirida
small
nonenvelop
virus
singlestrand
positivesens
rna
genom
unlik
enterovirus
also
picornavirida
rhinovirus
inactiv
expos
mild
acid
ph
account
failur
infect
gastrointestin
tract
rhinovirus
also
caus
otiti
media
infant
children
recov
middl
ear
fluid
subacut
chronic
case
neg
bacteria
recent
studi
associ
rhinoviru
infect
exacerb
asthma
acut
lower
respiratori
tract
diseas
especi
person
chronic
obstruct
airway
diseas
cystic
fibrosi
immunocompromis
rhinovirus
prefer
grow
lower
temperatur
mani
respiratori
virus
grow
less
well
higher
temperatur
lung
nose
howev
establish
infect
lung
typespecif
immun
develop
follow
infect
character
igg
neutral
antibodi
serum
secret
long
last
immun
best
correl
level
secret
iga
antibodi
nasal
mucou
membran
diagnosi
rhinoviru
infect
rare
requir
laboratori
test
viru
isol
detect
viral
rna
rtpcr
antigen
detect
dif
cell
respiratori
secret
detect
fourfold
rise
antibodi
titr
neutral
test
eia
perform
requir
viral
isol
cell
cultur
sensit
especi
collect
earli
ill
viral
isol
labour
intens
requir
sever
day
confirm
individu
rhinoviru
serotyp
requir
antigen
character
typespecif
antibodi
therefor
use
routin
diagnost
test
rtpcr
unlik
avail
except
research
procedur
human
coronavirus
import
caus
common
cold
belong
famili
coronavirida
genu
coronaviru
envelop
helic
nucleocapsid
possess
singlestrand
positivesens
rna
genom
coronaviru
infect
occur
sporad
throughout
winter
spring
distribut
worldwid
spread
larg
droplet
via
respiratori
rout
children
commonli
experi
one
coronaviru
infect
per
year
three
time
frequent
adult
coronavirus
associ
upper
respiratori
tract
ill
mainli
caus
common
cold
otiti
media
pneumonia
rare
occur
nonsar
coronaviru
infect
typespecif
antibodi
singl
coronaviru
type
develop
respons
infect
persist
month
circul
mucos
antibodi
confer
protect
ill
possess
coronaviru
antibodi
increas
age
circul
antibodi
found
children
older
year
nevertheless
reinfect
common
laboratori
diagnosi
coronaviru
infect
achiev
use
viru
isol
detect
viral
antigen
detect
viral
rna
rtpcr
andor
demonstr
fourfold
greater
rise
antibodi
titr
convalesc
viru
isol
complic
gener
recommend
routin
diagnost
test
sinc
ill
minor
common
cold
procedur
antibodi
measur
includ
elisa
neutral
hemagglutin
inhibit
sar
first
recogn
china
novemb
rapidli
spread
around
world
signific
morbid
mortal
cluster
affect
patient
eg
healthcar
worker
famili
contact
coronaviru
identifi
caus
interestingli
children
adolesc
significantli
less
sever
diseas
adult
sar
coronaviru
detect
use
rtpcr
viral
cultur
due
high
transmiss
agent
sever
outcom
patient
consid
sar
isol
laboratori
specimen
collect
high
level
precaut
laboratori
notifi
cultur
sar
coronaviru
attempt
high
biocontain
facil
specimen
may
need
referr
extern
public
health
laboratori
dutch
research
report
isol
agent
induc
cytopath
effect
cultur
cell
respiratori
specimen
collect
year
period
electron
microscopi
reveal
filament
virallik
particl
suggest
agent
viru
use
random
arbitrarili
primedpcr
viru
discov
found
member
paramyxovirida
famili
first
human
pathogen
genu
metapneumoviru
name
human
metapneumoviru
hmpv
sinc
initi
discoveri
hmpv
identifi
worldwid
gener
hmpv
infect
account
approxim
paediatr
lower
respiratori
ill
rtpcr
detect
reliabl
method
detect
present
standard
method
isol
hmpv
cultur
although
possibl
monoclon
antibodi
detect
viru
dif
test
clinic
util
human
bocaviru
newli
discov
parvoviru
first
identifi
sweden
occur
global
bocaviru
detect
young
children
respiratori
distress
mani
pneumonia
interstiti
infiltr
note
chest
xray
howev
whether
bocaviru
caus
respiratori
diseas
yet
fulli
determin
common
cold
common
usual
selfdiagnos
term
cold
constitut
singl
viral
entiti
rather
syndrom
nasal
congest
sneez
rhinorrhoea
pharyng
sever
clinic
diseas
associ
high
fever
children
cold
gener
selflimit
median
durat
day
mani
virus
varieti
viral
famili
may
associ
syndrom
pattern
symptom
associ
cold
appear
vari
significantli
agent
approxim
cold
found
associ
rhinoviru
infect
frequent
occur
agent
includ
coronavirus
enterovirus
nonprimari
infect
parainfluenza
viru
rsv
transmiss
virus
respons
common
cold
direct
contact
inocul
viru
upper
respiratori
tract
infect
rhinoviru
result
develop
long
last
antibodi
protect
reinfect
serotyp
also
produc
degre
resist
challeng
heterolog
rhinoviru
serotyp
protect
incomplet
short
live
recogn
complic
cold
includ
secondari
bacteri
infect
paranas
sinus
andor
middl
ear
exacerb
asthma
bronchiti
viral
otiti
media
commonli
complic
cold
children
probabl
due
eustachian
tube
dysfunct
rhinovirus
rsv
influenza
viru
adenoviru
detect
middl
ear
fluid
case
otiti
media
effus
children
specif
viral
diagnosi
gener
attempt
requir
isol
aetiolog
agent
cell
cultur
perform
rtpcr
may
sensit
detect
agent
especi
rhinovirus
enterovirus
coronavirus
pharyng
common
reason
seek
outpati
medic
care
divid
syndrom
nasal
symptom
predomin
viral
caus
case
without
nasal
symptom
caus
divers
spectrum
aetiolog
agent
includ
group
nongroup
streptococci
chlamydia
pneumonia
mycoplasma
pneumonia
epsteinbarr
viru
croup
viral
laryngotracheobronch
clinic
distinct
ill
predomin
affect
children
year
age
characterist
physic
find
croup
inspiratori
stridor
piv
account
case
croup
piv
piv
commonli
associ
caus
croup
includ
rsv
influenza
b
rhinovirus
adenovirus
well
pneumonia
pneumonia
influenza
tend
caus
croup
older
children
piv
influenza
associ
sever
diseas
gener
clinic
present
croup
syndrom
due
individu
agent
similar
measl
rare
caus
croup
caus
especi
sever
diseas
specif
viral
caus
croup
establish
viral
cultur
routin
perform
clinic
syndrom
suffici
diagnosi
manag
bronchiol
due
inflamm
bronchiol
lead
clinic
syndrom
characteris
obstruct
expiratori
airflow
usual
proceed
nasal
congest
rhinorrhea
may
often
histori
exposur
adult
sibl
cold
minor
respiratori
ill
exposur
anoth
infant
bronchiol
within
day
care
set
mild
conjunct
may
occur
one
third
case
otiti
media
recogn
hospit
cours
variabl
infant
improv
within
day
bronchiol
diseas
predomin
infanc
epidemiolog
diseas
close
parallel
incid
major
infecti
caus
rsv
peak
incid
age
infant
month
case
occur
first
year
life
rsv
caus
major
case
bronchiol
howev
respiratori
virus
includ
piv
influenza
rhinovirus
piv
adenoviru
type
rel
uncommon
may
associ
sever
diseas
includ
bronchiol
obliteran
rhinovirus
caus
bronchiol
infant
bronchopulmonari
dysplasia
pertussi
occasion
confus
bronchiol
anatom
defect
vascular
ring
foreign
bodi
gastrooesophag
reflux
addit
differenti
diagnos
bronchiol
pneumonia
part
spectrum
lower
respiratori
tract
involv
frequent
coexist
clearli
distinguish
pneumonia
defin
develop
abnorm
alveolar
ga
exchang
accompani
inflamm
lung
parenchyma
often
associ
visibl
chang
chest
xray
ct
scan
gallium
scan
consider
varieti
present
viral
pneumonia
depend
age
immunolog
compet
host
well
specif
viral
pathogen
viral
pneumonia
import
caus
morbid
mortal
individu
compromis
immun
system
clinic
present
vari
consider
specif
caus
agent
typic
includ
fever
lower
respiratori
tract
symptom
sign
tachypnoea
nonproduct
cough
wheez
increas
breath
sound
young
infant
may
present
apnoeic
episod
minim
fever
bacteri
superinfect
potenti
seriou
complic
viral
lower
respiratori
tract
infect
particularli
influenza
underli
cardiopulmonari
diseas
valvular
heart
diseas
chronic
obstruct
pulmonari
diseas
well
recogn
risk
factor
increas
sever
diseas
viral
pneumonia
diagnosi
specif
caus
acut
pneumonia
due
particular
viral
agent
complic
difficulti
obtain
appropri
lower
respiratori
tract
sampl
cultur
isol
detect
certain
pathogen
addit
frequent
asymptomat
shed
virus
eg
herp
simplex
viru
adenovirus
virus
clearli
import
frequent
caus
pneumonia
young
children
less
appar
older
children
rsv
associ
largest
proport
viral
pneumonia
young
children
particularli
accompani
bronchiol
piv
influenza
b
signific
caus
pneumonia
children
especi
period
epidem
preval
adenovirus
frequent
isol
children
respiratori
diseas
implic
childhood
pneumonia
howev
true
impact
difficult
access
long
intermitt
asymptomat
respiratori
shed
adenovirus
children
adenovirus
describ
caus
signific
outbreak
viral
pneumonia
institution
children
pneumonia
frequent
seriou
complic
measl
rhinovirus
associ
communityacquir
pneumonia
children
despit
appar
temperatur
sensit
occasion
caus
enterovirus
hsv
vsv
serolog
diagnosi
essenti
establish
tempor
causal
relationship
viral
infect
clinic
syndrom
posit
serolog
result
may
mislead
time
high
preval
particular
viral
agent
